Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study.

CORONA HOTSPOT COVID-19 CROSS-SECTIONAL STUDY SARS-COV-2 SEROLOGICAL STUDY STUDY PROTOCOL

Journal

Journal of health monitoring
ISSN: 2511-2708
Titre abrégé: J Health Monit
Pays: Germany
ID NLM: 101757730

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 28 07 2020
accepted: 06 08 2020
entrez: 11 2 2022
pubmed: 18 11 2020
medline: 18 11 2020
Statut: epublish

Résumé

At a regional and local level, the COVID-19 pandemic has not spread out uniformly and some German municipalities have been particularly affected. The seroepidemiological data from these areas helps estimate the proportion of the population that has been infected with SARS-CoV-2 (seroprevalence), as well as the number of undetected infections and asymptomatic cases. In four municipalities which were especially affected, 2,000 participants will be tested for an active SARS-CoV-2 infection (oropharyngeal swab) or a past infection (blood specimen IgG antibody test). Participants will also be asked to fill out a short written questionnaire at study centres and complete a follow-up questionnaire either online or by telephone, including information on issues such as possible exposure, susceptability, symptoms and medical history. The CORONA-MONITORING lokal study will allow to determine the proportion of the population with SARS-CoV-2 antibodies in four particularly affected locations. This study will increase the accuracy of estimates regarding the scope of the epidemic, help determine risk and protective factors for an infection and therefore also identify especially exposed groups and, as such, it will be crucial towards planning of prevention measures.

Identifiants

pubmed: 35146295
doi: 10.25646/7053
pmc: PMC8734078
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2-16

Informations de copyright

© Robert Koch Institute. All rights reserved unless explicitly granted.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declared no conflicts of interest.

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):620-30
pubmed: 23703478
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Jul;58(7):749-57
pubmed: 25986532
Lancet Infect Dis. 2020 Aug;20(8):920-928
pubmed: 32422201
Indian J Public Health. 2020 Jun;64(Supplement):S139-S141
pubmed: 32496245
Br J Psychiatry. 1995 Jan;166(1):29-34
pubmed: 7894872
J Hosp Infect. 2020 Jun;105(2):111-112
pubmed: 32277963
Arch Public Health. 2017 Sep 18;75:40
pubmed: 28936356

Auteurs

Claudia Santos-Hövener (C)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Markus A Busch (MA)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Carmen Koschollek (C)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Martin Schlaud (M)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Jens Hoebel (J)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Robert Hoffmann (R)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Hendrik Wilking (H)

Robert Koch Institute, Berlin Department of Infectious Disease Epidemiology.

Sebastian Haller (S)

Robert Koch Institute, Berlin Department of Infectious Disease Epidemiology.

Jennifer Allen (J)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Jörg Wernitz (J)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Hans Butschalowsky (H)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Tim Kuttig (T)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Silke Stahlberg (S)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Julia Strandmark (J)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Angelika Schaffrath Rosario (AS)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Antje Gößwald (A)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Andreas Nitsche (A)

Robert Koch Institute, Berlin Centre for Biological Threats and Special Pathogens.

Osamah Hamouda (O)

Robert Koch Institute, Berlin Department of Infectious Disease Epidemiology.

Christian Drosten (C)

Charité - Universitätsmedizin Berlin Institute of Virology, National Consultant Laboratory for Coronaviruses.

Victor Corman (V)

Charité - Universitätsmedizin Berlin Institute of Virology, National Consultant Laboratory for Coronaviruses.

Lothar H Wieler (LH)

Robert Koch Institute, Berlin Institute Leadership.
Robert Koch Institute, Berlin Methodology and Research Infrastructure.

Lars Schaade (L)

Robert Koch Institute, Berlin Centre for Biological Threats and Special Pathogens.
Robert Koch Institute, Berlin Institute Leadership.

Thomas Lampert (T)

Robert Koch Institute, Berlin Department of Epidemiology and Health Monitoring.

Classifications MeSH